FDA OKs Vascular Architects' latest stent:
This article was originally published in Clinica
Vascular Architects has received US FDA 510(k) clearance to market its next generation aSpire covered stent and 718 delivery system for treating tracheobronchial strictures. The device, which is now compatible with a 7-French introducer sheath, incorporates several improvements over its earlier generation device that make it even easier to use, says the San Jose, California firm.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.